Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: A beneficial levels of 25-hydroxyvitamin D for a decrease in thyrotropin receptor antibody (TRAB) in patients with Graves’ disease: a real-world study

Fig. 2

Changes in FT3, FT4, TSH, and TRAB in the 72 GD patients with different levels of 25-hydroxyvitamin D.*using a variance analysis, the pairwise relationships were studied using Least-Significant Difference (LSD) p < 0.05. #using a rank sum test, the pairwise relationships were studied using Nemenyi test p < 0.05

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us